Segall Bryant & Hamll Intl Eq Retl holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Segall Bryant & Hamill International Equity Fund - Retail Class CIQRX
- NAV / 1-Day Return 16.51 / +0.92 %
- Total Assets 15.8M
-
Adj. Expense Ratio
0.990%
- Expense Ratio 1.040%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.16%
- Turnover 107%
USD | NAV as of Sep 12, 2026 | 1-Day Return as of Sep 12, 2026, 12:25 AM GMT+0
Morningstar’s Analysis CIQRX
Will CIQRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Roche Holding AG Ordinary Shares new | 2.38 | 350,583 | Healthcare |
ASML Holding NV | 2.02 | 296,729 | Technology |
Banco Bilbao Vizcaya Argentaria SA | 1.79 | 262,971 | Financial Services |
Novartis AG Registered Shares | 1.69 | 248,531 | Healthcare |
BNP Paribas Act. Cat.A | 1.65 | 242,528 | Financial Services |
UniCredit SpA | 1.55 | 227,651 | Financial Services |
GSK PLC | 1.49 | 218,495 | Healthcare |
NatWest Group PLC | 1.40 | 206,559 | Financial Services |
Nomura Holdings Inc | 1.22 | 178,902 | Financial Services |
Danske Bank AS | 1.22 | 178,862 | Financial Services |